Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in Petros Pharmaceuticals, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- No complete 13F data for Q4 2020
- Shares held
- 1.14M
- No complete 13F data for Q4 2020
- Total value
- $4.23M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting PTPI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 15 | $77.6K |
| Q4 2024 | 9 | $38.5K |
| Q3 2024 | 11 | $59.2K |
| Q2 2024 | 12 | $94.9K |
| Q1 2024 | 13 | $94.9K |
| Q4 2023 | 16 | $164.7K |
| Q3 2023 | 14 | $170.6K |
| Q2 2023 | 14 | $214.3K |
| Q1 2023 | 9 | $42.7K |
| Q4 2022 | 10 | $90.6K |
| Q3 2022 | 13 | $355.0K |
| Q2 2022 | 16 | $558.0K |
| Q1 2022 | 19 | $1.30M |
| Q4 2021 | 21 | $3.58M |
| Q3 2021 | 19 | $1.82M |
| Q2 2021 | 22 | $3.02M |
| Q1 2021 | 20 | $4.23M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Petros Pharmaceuticals, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 11 | $0 | 0.00% | – | – |
| Wells Fargo & Company | 28 | $0 | 0.00% | – | – |
| First Manhattan Co | 100 | $0 | 0.00% | – | – |
| Morgan Stanley | 169 | $1.00K | 0.00% | – | – |
| Cutler Group LP | 340 | $1.00K | 0.00% | – | – |
| Royal Bank of Canada | 2,000 | $7.00K | 0.00% | – | – |
| Advisor Group Holdings, Inc. | 1,895 | $7.00K | 0.00% | – | – |
| Brewin Dolphin Ltd | 2,143 | $7.99K | 0.00% | – | – |
| Geode Capital Management, LLC | 14,180 | $52.0K | 0.00% | – | – |
| BlackRock Inc. | 18,277 | $68.0K | 0.00% | – | – |
| FNY Investment Advisers, LLC | 20,000 | $73.0K | 0.03% | – | – |
| Neville Rodie & Shaw Inc | 21,875 | $82.0K | 0.01% | – | – |
| Citadel Advisors LLC | 35,492 | $131.0K | 0.00% | – | – |
| Spire Wealth Management | 44,000 | $161.0K | 0.00% | – | – |
| CM Management, LLC | 45,000 | $168.0K | 0.12% | – | – |
| Acorn Financial Advisory Services Inc | 62,700 | $234.0K | 0.09% | – | – |
| Vanguard Group Inc | 88,704 | $331.0K | 0.00% | – | – |
| Renaissance Technologies LLC | 185,545 | $692.0K | 0.00% | – | – |
| Shay Capital LLC | 256,670 | $957.0K | 0.27% | – | – |
| NorthRock Partners, LLC | 337,531 | $1.26M | 0.11% | – | – |